Scarica l'app Stockscreener
37.10
0.16%
-0.06
Mineralys Therapeutics Inc Borsa (MLYS) Ultime notizie
Is Mineralys Therapeutics Inc. stock oversold or undervaluedInsider Selling & Long-Term Investment Growth Plans - baoquankhu1.vn
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN
How Mineralys Therapeutics Inc. stock compares to market leadersEarnings Growth Summary & Trade Opportunity Analysis Reports - baoquankhu1.vn
Srinivas Akkaraju Purchases 588,235 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat
Polar Asset Management Partners Inc. Trims Stock Holdings in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys Reports Strong Phase 3 Results for Lorundrostat in High-Risk Hypertension Patients - MSN
Parkman Healthcare Partners LLC Purchases New Holdings in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Cinctive Capital Management LP Acquires New Holdings in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Wall Street Analysts Believe Mineralys Therapeutics, Inc. (MLYS) Could Rally 149.66%: Here's is How to Trade - MSN
The Goldman Sachs Group Increases Mineralys Therapeutics (NASDAQ:MLYS) Price Target to $52.00 - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Director Ra Capital Management, L.P. Purchases 1,176,470 Shares - MarketBeat
Trexquant Investment LP Purchases New Position in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week HighHere's Why - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Given "Buy" Rating at HC Wainwright - MarketBeat
Aldosterone Synthase Inhibitors Market Outlook (2025-2032) : - openPR.com
Mineralys Therapeutics Reaches Analyst Target Price - Nasdaq
Mineralys Therapeutics stock hits all-time high at 37.42 USD By Investing.com - Investing.com Australia
Mineralys Therapeutics (NASDAQ:MLYS) Trading 5.3% Higher Following Analyst Upgrade - MarketBeat
Why Mineralys Therapeutics Stock is Climbing - TipRanks
279,500 Shares in Mineralys Therapeutics, Inc. $MLYS Bought by Canada Pension Plan Investment Board - MarketBeat
Hedge Fund and Insider Trading News: Louis Bacon, Bill Ackman, Warren Buffett, Dan Loeb, Silver Point Capital, Starboard Value, Elliott Management, Mineralys Therapeutics Inc (MLYS), DuPont de Nemours Inc (DD), and More - Insider Monkey
Mineralys Therapeutics stock hits all-time high at 37.42 USD - Investing.com
What Makes Mineralys Therapeutics, Inc. (MLYS) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Tuesday 9/9 Insider Buying Report: MLYS, KMTS - Nasdaq
Mineralys Therapeutics Stock (MLYS) Opinions on $175M Public Offering and Clinical Trial Results - Quiver Quantitative
Is Summit Therapeutics a Buy, Sell, or Hold Now? - AOL.com
Major Investment Alert: Mineralys Therapeutics Sees Huge Stock Purchase! - TipRanks
Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap DownTime to Sell? - MarketBeat
Ra Capital Healthcare Fund buys Mineralys Therapeutics shares for $30m By Investing.com - Investing.com South Africa
Ra Capital Healthcare Fund buys Mineralys Therapeutics shares for $30m - Investing.com Nigeria
Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Phase 3 Results and Strong Financial Position - TipRanks
H.C. Wainwright reiterates Buy rating on Mineralys stock, citing lorundrostat potential - Investing.com Nigeria
Mineralys Therapeutics Shares Surge on Promising Trial Results - TipRanks
Drawdown in Mineralys Therapeutics Inc. May Be Nearing EndQuarterly Profit Summary & Breakout Confirmation Trade Signals - beatles.ru
Should value investors consider Mineralys Therapeutics Inc.July 2025 Trade Ideas & Real-Time Price Movement Reports - beatles.ru
Will Mineralys Therapeutics Inc. benefit from current market trendsMarket Performance Summary & Precise Buy Zone Identification - 뉴스영
Buy Rating Affirmed for Mineralys Therapeutics Due to Promising Hypertension Drug Data and Market Position - TipRanks
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 1-Year HighShould You Buy? - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Price Target Raised to $26.00 - MarketBeat
Mineralys Therapeutics prices upsized $250M stock offering - MSN
Jefferies expects Mineralys stock to trade up following AstraZeneca data - MSN
Mineralys Therapeutics, Inc. $MLYS Shares Sold by ADAR1 Capital Management LLC - MarketBeat
How moving averages guide Mineralys Therapeutics Inc. trading2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
Is Mineralys Therapeutics Inc. affected by consumer sentiment2025 Volume Leaders & Reliable Volume Spike Trade Alerts - خودرو بانک
Is Mineralys Therapeutics Inc. undervalued by DCF analysisWeekly Trend Report & Smart Swing Trading Techniques - خودرو بانک
Mineralys reports positive subgroup data for hypertension drug By Investing.com - Investing.com Canada
Can Mineralys Therapeutics Inc. disrupt its industryJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
0.93%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):